Acumen Pharmaceuticals Inc
ABOS
Get informed when a big investor buys or sells
+ FollowMarket Cap$142.95M
Close$
$0.37
86.3% downside
Current Fair Value
86.3% downsideOvervalued by 86.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $142.95 Million |
|---|---|
| Enterprise Value | $105.28 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2 |
| Beta | 0.35 |
| Outstanding Shares | 63,219,289 |
Return
| Return on Equity | -129.49% |
|---|---|
| Return on Assets | -84.77% |
| Return on Invested Capital | -108.70% |
Valuation & Multiples
| P/E Ratio | -1.26 |
|---|---|
| PEG | 4.51 |
| Price to Sales | -2.74 |
| Price to Book Ratio | 2.74 |
| Enterprise Value to Revenue | -1169.78 |
| Enterprise Value to EBIT | -0.93 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.13 |
| Debt to Equity | 0.16 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 19, 2026
EPS Estimate
$-0.35
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 11, 2026
EPS Estimate
$-0.39
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.0891▲ 108.91% |
|---|---|
| Total Calls | 79,700▲ 197.39% |
| Total Puts | 86,800▲ Infinity% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 75.96%▲ 17.09% |
|---|---|
| Total Invested | $108.54M▲ 44.26% |
| Investors Holding | 89▲ 18.00% |
ESG Score
No data
About Acumen Pharmaceuticals Inc
2,021 employees